glp 1 agonists moa GLP-1 - What is it? The Road towards Triple Agonists:
Description
Health economists and payers want to know the true eligible population and budget impact
Nausea, constipation , and fatigue are the most commonly reported issues
Another meta-analysis on pancreatic cancer specifically also showed that GLP-1RAs were not associated with increased risk for pancreatic cancer as compared with other treatments (93)
Diabetes Obesity and Metabolism
In summary, a reduced incretin effect on insulin secretion is associated with both genetic and metabolic alterations
